Simulations Plus Announces Q2 FY26 Earnings Date and Conference Call

jueves, 26 de marzo de 2026, 4:10 pm ET1 min de lectura
SLP--

Simulations Plus, a global leader in model-informed and AI-accelerated drug development, announced Q2 FY26 earnings and a conference call for April 9, 2026. The company reported a 3% decrease in total revenue to $18.4 million, with software revenue down 17% to $8.9 million. The conference call will discuss the results and provide insights into the company's strategic direction.

Simulations Plus Announces Q2 FY26 Earnings Date and Conference Call

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios